2024-04-08 05:47:00 ET
Two adages capture the dilemma investors face when they consider buying a beaten-down stock:
These well-known sayings seem to be contradictory. However, they're not when taken in the correct context. Some sinking stocks have poor underlying businesses and should be avoided -- just like a falling knife. Others have solid underlying businesses and are likely to rebound over time.
I think Pfizer (NYSE: PFE) falls into the latter category. This S&P 500 dividend stock could be the best bad-news buy on the market.
For further details see:
This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the market